Other languages ALTEOGEN Inc.

Equities

A196170

KR7196170005

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-05-16 pm EDT			5-day change	1st Jan Change
189,600 ^KRW	+6.52%		+11.40%	+92.49%

2023	Alteogen Inc. Announces Clinical Trial of Tergase Showed Zero Incidence of ADA	CI
2023	ALTEOGEN Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Alteogen Inc. Announces Clinical Trial of Tergase Showed Zero Incidence of ADA	23-09-05
ALTEOGEN Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15
ALTEOGEN Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-20
ALTEOGEN Inc. Enters into an Exclusive License Agreement to Develop and Commercialize Biosimilar Products Enabled by its Hybrozyme Technology	23-01-02

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.

BENEFIT NOW